干燥甲状腺提取物治疗甲状腺功能减退症的潜在风险与获益:一项系统综述
该系统综述检索至2024年1月6日的六个电子数据库,纳入9项非随机干预研究、2项随机临床试验和3例病例报告,比较干燥甲状腺提取物与左甲状腺素或左甲状腺素联合碘塞罗宁治疗成人甲状腺功能减退症。随机临床试验未发现生活质量或症状评分差异,非随机研究则偏向干燥甲状腺提取物;干燥甲状腺提取物可能升高心率、降低体重和高密度脂蛋白,但结果矛盾。总体证据质量中至极低,长期效应和副作用数据缺乏。
要点
- 两项随机临床试验未显示干燥甲状腺提取物与其他甲状腺激素替代在生活质量或症状评分上有差异。
- 非随机研究中症状和生活质量评估偏向干燥甲状腺提取物。
- 干燥甲状腺提取物可能升高心率、降低体重和高密度脂蛋白,但结果矛盾。
核心结论
- 多数干燥甲状腺提取物研究因设计较差而受限,且缺乏长期效应和副作用数据。
- 两项随机临床试验未能证明干燥甲状腺提取物与其他甲状腺激素替代在生活质量或症状评分上有任何差异。
- 未来干燥甲状腺提取物试验应基于 adequate 研究设计、经过验证的生活质量测量、生活质量降低的患者以及反映长期不良反应的生物标志物评估。
研究设计与样本
- 系统综述,检索截至2024年1月6日的六个电子数据库,由两名评价者独立筛选搜索结果。
- 纳入9项非随机干预研究、2项随机临床试验和3例病例报告,比较干燥甲状腺提取物与左甲状腺素或左甲状腺素联合碘塞罗宁治疗。
- 主要结局为生活质量,次要结局包括症状、治疗偏好、不良反应、甲状腺激素水平、甲状腺自身抗体、心血管指标和脱碘酶基因多态性。
主要发现
- 随机临床试验发现治疗间生活质量无差异,症状评分评估也无差异。
- 非随机干预研究中,症状和生活质量评估偏向干燥甲状腺提取物。
- 纳入研究表明干燥甲状腺提取物与其他治疗方案相比可能升高心率、降低体重和降低高密度脂蛋白,但结果矛盾。
- 各种结局的总体证据质量为中至极低。
临床怎么用
- 干燥甲状腺提取物不再推荐用于甲状腺功能减退症的治疗,但仍在使用。
- 原文未据此给出推荐。
局限性
- 多数干燥甲状腺提取物研究因设计较差而受限。
- 缺乏长期效应和副作用数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Desiccated thyroid extract (DTE) is no longer recommended for the treatment of hypothyroidism but is still in use. This review aimed to summarize the available literature on treatment with DTE in adult patients with hypothyroidism. Methods: The search was conducted up until January 6, 2024, in six electronic databases. Two reviewers independently screened all the search results. The retrieved studies compared DTE treatment with levothyroxine or combination therapy with liothyronine and levothyroxine. The primary outcome was quality of life (QoL), and the secondary outcomes included symptoms, treatment preference, adverse effects, thyroid hormone levels, thyroid autoantibodies, cardiovascular measures, and gene polymorphisms in deiodinase enzymes. Results: In the qualitative synthesis, we included nine nonrandomized studies of interventions (NRSIs), two randomized clinical trials (RCTs), and three case reports. The overall quality of evidence was moderate to very low for the various outcomes. The RCTs found no difference between treatments regarding QoL and symptom score assessments. In the NRSIs, symptom and QoL assessments were in favor of DTE. The included studies indicated that DTE may cause an increase in heart rate, lower body weight, and lower high-density lipoprotein compared with other treatment regimens, but results were conflicting. Conclusions: Most studies of DTE treatment are hampered by an inferior design, and data on long-term effects and side effects are lacking. Two RCTs could not demonstrate any difference in QoL or symptom scores when comparing DTE with other thyroid hormone substitutions. Future trials of DTE in patients with hypothyroidism should be based on adequate study designs, validated measures of QoL, patients with reduced QoL, and the assessment of biomarkers reflecting long-term adverse effects.
引用
- Riis KR, Larsen CB, Bonnema SJ, et al. Potential Risks and Benefits of Desiccated Thyroid Extract for the Treatment of Hypothyroidism: A Systematic Review. Thyroid. 2024. PMID: 38526391. doi:10.1089/thy.2023.0649
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。